Daily Reporter

Today Don't Miss

Today Don't Miss

Are we reaching a turning point in metastatic prostate cancer?

At yesterday’s Presidential Symposium, a Late-Breaking Abstract presentation of the PROfound study reported a clinically meaningful benefit in radiological progression-free survival (PFS) with olaparib in men with BRCA1, BRCA2 or ATM mutations in metastatic castration-resistant…

Read More

Slow progress on female leadership in oncology

“Gender-related issues are not only of interest to female professionals, but the whole oncology community would benefit from ensuring a level playing field,” says Prof. Solange Peters from Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland,…

Read More




Towards diagnosis of minimal residual disease

With technological advances increasing the sensitivity and specificity of testing, liquid biopsies are fast making their mark as a diagnostic test for minimal residual disease (MRD), providing guidance on how to tailor treatment for early-stage…

Read More